Ibrutinib Impurity 78 | CAS 143667-36-1 - Request Quote
Ibrutinib Impurity 78
| SZ CAT No: | SZ-I005102 |
| CAS No | 143667-36-1 |
| Mol.F. | C13H12N2O2 |
| Mol.Wt. | 228.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 78 is chemically 4-Phenoxybenzohydrazide. Ibrutinib Impurity 78 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 78 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 143667-36-1
Purchase 143667-36-1
Order 143667-36-1
Enquire 143667-36-1
price of 143667-36-1
143667-36-1 Supplier
143667-36-1 Manufacturer
143667-36-1 Exporter
buy high quality Ibrutinib Impurity 78
Purchase Ibrutinib Impurity 78
Ibrutinib Impurity 78 suppliers
Ibrutinib Impurity 78 manufacturers
Ibrutinib Impurity 78 price
Order Ibrutinib Impurity 78
Enquire Ibrutinib Impurity 78
Ibrutinib Impurity 78 cost
Ibrutinib Impurity 78 Supplier
Ibrutinib Impurity 78 Distributor
Ibrutinib Impurity 78 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 78 for ANDA Filing
Ibrutinib Impurity 78 for Forced Degradation Studies
Ibrutinib Impurity 78 Identification Standards
Ibrutinib Impurity 78 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.